Resources | NITAG RESOURCE CENTER

2023

Updated HPV Technical Dossier on Quadrivalent HPV (Gardasil-4valent) 1-dose Regimen

2023 ∙ NACI

NACI guidance on COVID-19 vaccine booster doses: Initial considerations for 2023

2023 ∙ NIAC

Recommendations for COVID-19 vaccination of children aged 6 months to 4 years

2022

Guidelines on Interagency Coordinating Committees

2022 ∙ NGI-TAG

Evidence and Recommendation on Quadrivalent Human Papillomavirus Vaccine introduction into Routine Immunization(RI) in the light of new evidence

2022 ∙ ATAGI

ATAGI statement on the intradermal use of Imojev Japanese encephalitis vaccine

2022 ∙ SAGE

Annexes to the 2022 WHO Hepatitis A Vaccine Position Paper

2022 ∙ SAGE

Background document for the SAGE April 2022 session on Hepatitis A vaccines

2022 ∙ SAGE

Hepatitis A childhood and adolescent vaccination: a systematic review of the effectiveness, immunogenicity, impact, safety and cost effectiveness of pediatric vaccines

2022 ∙ SAGE

Should an off-label , permissive one-dose HPV vaccine schedule for use in routine and/or multi-age cohort (MAC) catch up strategies be recommended?